20212 ⎘
Medicinal preparations containing organic active ingredients Ketones
USE OF XANTHOHUMOL AND/OR ISOXANTHOHUMOL AS AN AGENT FOR PREVENTING AND/OR COMBATING LIVER DISEASES
#1502Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
#1503Method of producing a safe, whole-extract of curcuma for oral and topical use
#1504Sunscreen comprising a curcuma extract
#1505NOVEL FORMULATIONS AND USES FOR CURCUMA EXTRACTS
#1506Lipophilic curcumin analogs and methods of inhibiting HIV-1, treating latent HIV in the brain, and preventing HIV-mediated cognitive decline and HIV dementia
#1507ANTIOXIDANT COMPOSITIONS FOR SOFT ORAL TISSUE AND METHODS OF FORMULATION AND USE THEREOF
#1508NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE EFFECT
#1509Oxidative retinal diseases
#1510PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-B-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS
#1511Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
#1512Methods and compositions of camel derived products
#1513Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#1514Process for oral care material taste and/or odor improvement
#1515PEST-IMPERVIOUS PACKAGING MATERIAL AND PEST-CONTROL COMPOSITION
#1516Solid forms of curcumin
#1517Therapy for leukemia
#1518Method for improving tetracycline-resistance of
#1519Curcuminoid composition with enhanced bioavailability and a process for its preparation
#1520Oxidosqualene cyclase as a protein target for anticancer therapeutics
#1521Methods of treating muscular wasting diseases using NF-KB activation inhibitors
#1522Compositions and methods for managing weight
#1523Use of panduratin derivatives or an extract of for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
#1524Methods for microbial biofilm destruction
#1525Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
#1526Ophthalmic solution for absorbing ultraviolet radiation and method for absorbing ultraviolet radiation
#1527SMART POLYMERIC NANOPARTICLES WHICH OVERCOME MULTIDRUG RESISTANCE TO CANCER THERAPEUTICS AND TREATMENT-RELATED SYSTEMIC TOXICITY
#1528Nanocrystals, compositions, and methods that aid particle transport in mucus
#1529Oral Composition for the Treatment of Acne
#1530Methods and compositions for the treatment of cancer
#1531MATERIALS AND METHODS FOR THE PROPHYLACTIC TREATMENT OF A PRE-MALIGNANT CONDITION
#1532PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE SUBSTANCE
#1533CURCUMINOID SOLID DISPERSION FORMULATION
#1534Transfer Factor Compositions
#1535PTEROSTILBENE AND CURCUMIN COMBINATION FOR TREATMENT OF OXIDATIVE STRESS AND INFLAMMATION
#1536Composition for promoting lipolysis
#1537AMYRIS ALCOHOL AND ITS ESTER FOR TREATING ACNE
#1538Pharmaceutical formulation for reducing frequency of urination and method of use thereof
#1539MODULATION OF HISTONE H2B MONOUBIQUITINATION AND TREATMENT OF CANCER
#1540Method of treating airway remolding symptom
#1541Water soluble composition comprising curcumin having enhanced bioavailability and process thereof
#1542METHOD FOR TREATMENT OF SORES IN THE ORAL CAVITY WITH A COMPOSITION CONTAINING ULTRAVIOLET LIGHT-ABSORBING INGREDIENTS
#1543Cosmetic or dermatological preparations containing licochalcone A or an extract of radix glycyrrhizae inflatae, containing licochalcone A
#1544Magnetic nanoparticle formulations, methods for making such formulations, and methods for their use
#1545CELLULOSE DERIVATIVES FOR ENHANCING BIOAVAILABILITY OF FLAVONOIDS
#1546Inhibitors of AkT activity
#1547Pharmaceutical compositions of curcumin
#1548Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
#1549Extended-release formulation for reducing the frequency of urination and method of use thereof
#1550Stat5b transgenic mice and methods of use thereof
#1551AGENT FOR INHIBITING ODOR OF PYRAZINE DERIVATIVES
#1552Method for treating Alzheimer's disease
#1553EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF
#1554Use of acacia extracts and their compounds on inhibition of xanthine oxidase
#1555Multiple sign bit hiding within a transform unit
#1556Cytochrome P450 2C9 Inhibitors
#1557Silicone scar treatment preparation
#1558Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
#1559Methods and materials for the generation of regulatory T cells
#1560PHARMACEUTICAL COMPOSITIONS
#1561Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
#1562Medical compositions containing liquorice extracts with synergistic effect
#1563Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1564CURCUMIN COMPOSITIONS AND USES THEREOF
#1565Methods and compositions for improving the health of animals
#1566COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CANCER BY TARGETING AND INHIBITING CANCER STEM CELLS
#1567METHODS OF REDUCING 15-F2T-ISOP LEVELS IN MAMMALS
#1568Method for treating cancer with agents that bind phosphorylated CDC27
#1569Anti-aging formulations
#1570Antioxidant composition
#1571Amido compounds as RORγt modulators and uses thereof
#1572ANTIOXIDATIVE AND HEPATOPROTECTIVE COMPOSITIONS CONTAINING DIARYLHEPTANOIDS FROM ALNUS JAPONICA
#1573Oral Formulations For Promoting Cellular Purification
#1574Compounds For Use In The Treatment Of Diseases
#1575ADHESIVE SLOW-RELEASE FORMULATIONS FOR THE LOCAL ADMINISTRATION OF CURCUMIN
#1576Boswellia oil, its fractions and compositions for enhancing brain function
#1577Method for inhibition of potential-dependent cation channel
#1578COMPOSITION FOR TREATING ATHEROSCLEROSIS AND A PREPARATION METHOD THEREOF
#1579DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE REINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#1580Formulations from derivatives of curcumin, paclitaxel, and aspirin
#1581MEDICATION FOR THERAPY OR PROPHYLAXIS OF ASTHMA
#1582TREATMENT OF ISCHEMIC TISSUE
#1583MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS
#1584NUTRITIONAL FORMULA FOR MANAGING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG HEALTH
#1585NUTRITIONAL FORMULA FOR MANAGING ANGINA PECTORIS
#1586FUNCTIONAL FOOD AND PHARMACEUTICAL COMPOSITIONS FOR ANTI-OBESITY COMPRISING CAPSANTHIN AND FATTY-ACYL ESTER OF CAPSANTHIN HAVING ANTI-ADIPOGENIC ACTIVITY
#1587EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#1588CANCER THERAPY
#1589Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
#1590Method of treating actinic keratosis and basal cell carcinoma
#1591Boswellia low polar gum resin extract and its synergistic compositions
#1592Inhibitor of protein crosslinking and use of the same
#1593Compositions and methods for treating fragile X premutation RVGG repeats-mediated toxicity
#1594Compositions that treat or inhibit pathological conditions associated with inflammatory response
#1595Eutectic-based self-nanoemulsified drug delivery system
#1596Bioavailability enhancing composition
#1597ANALGESIC COMBINATION OF OPIOID ANALGESIC AND CYCLOOXYGENASE-2 INHIBITOR
#1598COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES OR DERIVATIVES THEREOF AND USES THEREOF
#1599TRITERPENE DERIVATIVE AND AGENT FOR PREVENTING OR TREATING CHRONIC HEPATITIS C
#1600TREATMENT COMPOSITION AND METHOD
#1601Modulation of osteoclast differentiation
#1602CURCUMIN COMBINATION WITH ANTI-TYPE 2 DIABETIC DRUGS FOR PREVENTION AND TREATMENT OF DISEASE SEQUELAE, DRUG-RELATED ADVERSE REACTIONS, AND IMPROVED GLYCEMIC CONTROL
#1603MEDICATION FOR CLINICAL EXTENSIVELY-DRUG RESISTANT ACINETOBACTER BAUMANNII
#1604Composition to enhance the bioavailability of curcumin
#1605Synergistic anti-inflammatory and antioxidant dietary supplement compositions
#1606Polymer conjugated protein micelles
#1607COMPOSITIONS COMPRISING POLYUNSATURATED FATTY ACID MONOGLYCERIDES, DERIVATIVES THEREOF AND USES THEREOF
#1608Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#1609Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
#1610Composition to enhance the bioavailability of curcumin
#1611Methods and Compositions for Treating Viral Hemorrhagic Fever
#1612CHEMICAL COMPOSITIONS TO DETECT AND TREAT AMYLOID IN A PATIENTS BRAIN AND RETINA
#1613Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism
#1614Cosmetic compositions comprising cyanodiphenylacrylates
#1615Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#1616Equine nutritional supplement
#1617Composition comprising turmeric extract and zedoary extract
#1618Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
#1619Family of PFKFB3 inhibitors with anti-neoplastic activities
#1620Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#1621Organonitro Compounds for Use in Treating Non-Hodgkin's Lymphoma and Leukemia, and Methods Relating Thereto
#1622METHOD OF EVALUATING SUITABILITY FOR DRUG THERAPY FOR THE PREVENTION AND TREATMENT OF ANXIETY DISORDERS USING CHOLINERGIC TYPE II THETA RHYTHM
#1623Fatty acids as anti-inflammatory agents
#1624Topical Compositions Comprising An Alkoxylated Diphenylacrylate Compound And An Aryl Carboxylic Ester
#1625Solubilized CoQ-10
#1626COMBINATION OF CURCUMINOIDS AND MTOR INHIBITORS FOR THE TREATMENT OF TAUOPATHIES
#1627Combination products
#1628Terpene glycosides and their combinations as solubilizing agents
#1629Topical Compositions Comprising Inorganic Particulates And An Alkoxylated Diphenylacrylate Compound
#1630Solubilized CoQ-10
#1631Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
#1632TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING SWINE INFLUENZA, PREPARATION METHOD AND USE THEREOF
#1633Synergistic combinations of cartonoids and polyphenols
#1634Submicron Particles of Antineoplastic Agents
#1635ALKYLSACCHARIDE COMPOSITIONS WITH NUTRACEUTICALS
#1636Zero Calorie Polyphenol Aqueous Dispersions
#1637Methods and systems for modulating hormones and related methods, agents and compositions
#1638Synergistic Composition for Enhancing Bioavailability of Curcumin
#1639Composition and method for inhibiting biogenic sulfide generation
#1640Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
#1641β- and γ-diketones and γ-hydroxyketones as /β-catenin signaling pathway activators
#1642Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells
#1643Antiviral Compounds and Methods of Using Thereof
#1644COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION INJURY
#1645Compositions for treating obesity and insulin resistance disorders
#1646METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE
#1647Curcuminoids in Combination Docetaxel for the Treatment of Cancer and Tumour Metastasis
#1648Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases
#1649CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS
#1650Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions
#1651Use of extracts and their compounds on inhibition of xanthine oxidase
#1652Composition to retard the onset of symptoms of alzheimer's disease
#1653Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules
#1654Self emulsifying drug delivery system for a curcuminoid based composition
#1655Liposomal curcumin for treatment of cancer
#1656Lactoferrin and angiogenin compositions and uses thereof
#1657METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE AND MODULATING TRANSIENT RECEPTOR POTENTIAL CHANNELS
#1658Natural extract containing xanthohumol, method for the production thereof and products produced therefrom
#1659COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE
#1660Therapeutic Liposomes and Methods For Producing and Using the Same
#1661Continuous administration of dopa decarboxylase inhibitors and compositions for same
#1662Compounds and compositions for reducing lipid levels
#1663Vitamin D promoting sunscreen
#1664Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's disease
#1665Modulation of axon degeneration
#1666Pharmaceutical composition comprising ginger extract or shogaol
#1667Drug Delivery Composition Comprising a Self-Assembled Gelator
#1668Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
#1669USE OF CURCUMIN OR ITS ANALOGUES IN CANCER THERAPY UTILIZING EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR
#1670Anti-virulence compositions and methods
#1671Compositions and methods for enhancing immune response
#1672THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ISOFLAVONES
#1673CURCUMINOIDS AND ITS METABOLITES FOR THE APPLICATION IN OCULAR DISEASES
#1674FERMENTED SOY NUTRITIONAL SUPPLEMENTS INCLUDING MUSHROOM COMPONENTS
#1675Production of organic compound nanoparticles with high repetition rate ultrafast pulsed laser ablation in liquids
#1676Compounds for treatment of malignant tumors
#1677CURCUMIN NANOPARTICLES AND METHODS OF PRODUCING THE SAME
#1678Methods and Compositions for Treating Alzheimer's Disease
#1679Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
#1680Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
#1681Therapeutic drug for adult T-cell leukemia
#1682ARTEMISININ AND DERIVATIVES THEREOF AS ANTIVIRALS
#1683COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
#1684Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids
#1685Composition of molecular elements for phosphorylase kinase inhibition
#1686COMPOSITION AND METHOD FOR INHIBITING NOROVIRUS INFECTION
#1687Therapeutic combinations for use in neoplasia
#1688ANTIOXIDATIVE AND HEPATOPROTECTIVE COMPOSITIONS CONTAINING DIARYHEPTANOIDS FROM ALNUS JAPONICA
#1689DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION DISEASES, SUCH AS DERMATITIS, ATOPIC DERMATITIS, VITILIGO, ALOPECIA AREATA, ACNE, PSORIASIS, PRURITUS OR COMBINATIONS OF SAME
#1690NOVEL DIARYL HEPATONOID-BASED COMPOUNDS AND USE THEREOF
#1691Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
#1692Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed
#1693Intravenous infusion of curcumin and a calcium channel blocker
#1694IDO INHIBITORS AND THERAPEUTIC USES THEREOF
#1695THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR
#1696Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease
#1697Ischemia/reperfusion protection compositions and methods of using
#1698Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
#1699Authoring Tool and Method for Creating an Electrical Document
#1700DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS
#1701Aminocarboxylic acid derivative and medicinal use thereof
#1702Composition to enhance the bioavailability of curcumin
#1703METHOD FOR TREATING OBESITY
#1704Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
#1705Composition to enhance the bioavailability of curcumin
#1706ANTIOXIDANT COMPOSITIONS FOR SOFT ORAL TISSUE AND METHODS OF FORMULATION AND USE THEREOF
#1707Inhibitors of AKT Activity
#1708Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
#1709Dietary Supplement Compositions and Methods of Making and Using the Same
#1710Dietary Supplement Compositions and Methods of Making and Using the Same
#1711Methods and compositions for modulating hair growth or regrowth
#1712Inhibitors of Akt activity
#1713Anti-bacterial composition comprising extract from barks of Matsum
#1714Modulation of inflammation by hops fractions and derivatives
#1715XANTHOHUMOL AND TETRAHYDRO-ISOALPHA ACID BASED PROTEIN KINASE MODULATION CANCER TREATMENT
#1716USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF ALPHA INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
#1717Compounds and method for coating surfaces in a hemocompatible manner
#1718Therapeutic Treatment Of Wounds
#1719Bioactive composition for the treatment of the HIV/AIDS, method for manufacturing and using the same
#1720Adrenomedullin production enhancer
#1721Methods of Administering Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitors
#1722SILICONE SCAR TREATMENT PREPARATION
#1723Method for reducing the weight of a subject or inhibiting weight gain in a subject
#1724Pharmaceutical Co-Crystal Compositions
#1725ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE
#1726Continuous administration of dopa decarboxylase inhibitors and compositions for same
#1727Continuous administration of dopa decarboxylase inhibitors and compositions for same
#1728Methods for ameliorating and preventing central nervous system inflammation
#1729Methylated curcumin-resveratrol hybrid molecules for treating cancer
#1730INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
#1731TREATMENT OF NEUROLOGICAL DISORDERS
#1732Shunt Delivery of Curcumin
#1733MICROTUBULE-DISRUPTNG AGENT AND CANCER CELL PROLIFERATION INHIBITOR CONTAINING THE SAME
#1734USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#1735DIHYDRONAPHTHYRIDINYL AND RELATED COMPOUNDS FOR USE IN TREATING OPHTHALMOLOGICAL DISORDERS
#1736Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome
#1737Inflammatory cytokine release inhibitor
#1738Inhibitors of Akt activity
#1739Anthracenedione compounds
#1740Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1741Nutritional Composition Comprising Curcuminoids and Methods of Manufacture
#1742Methods for making nutritional compositions comprising curcuminoids
#1743SELECTIVE PROTEASOME INHIBITORS FOR TREATING DIABETES
#1744Pest-impervious packaging material and pest-control composition
#1745Dual modulation of endocannabinoid transport and fatty-acid amide hydrolase for treatment of excitotoxicity
#1746Composition to enhance the bioavailability of curcumin
#1747ANTIDIARRHETIC COMPOSITION, PRODUCT CONTAINING THE SAME AND METHOD OF PREVENTING DIAHHREA
#1748MODULATION OF NEUROGENESIS USING D-CYCLOSERINE COMBINATIONS
#1749Biodegradable cationic polymers
#1750MULTILAYERED VITAMIN COMPLEX TABLET CONTAINING UBIDECARENONE
#1751Ischemia/reperfusion protection compositions and methods of using
#1752Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#1753Composition for treating atopic dermatitis comprising hirsutenone as an active ingredient
#1754Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient
#1755Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
#1756Pulsatile Dosing of Gossypol for Treatment of Disease
#1757Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
#1758DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#1759Acne treatment powder foundation
#1760ANTIOXIDANT COMPOSITIONS FOR SOFT ORAL TISSUE AND METHODS OF FORMULATION AND USE THEREOF
#1761Eutectic-based self-nanoemulsified drug delivery system
#1762METHODS OF REDUCING 15-F2T-ISOP LEVELS IN MAMMALS
#1763Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
#1764DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, AN ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE
#1765Treatment of Viral Infections
#1766Determining nutrients for animals through gene expression
#1767Prevention of Cancers by Immunization
#1768VAGINAL ODORANTS
#1769SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH
#1770Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
#1771METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#1772Antimicrobial efficacy of aframomum Melegueta extract against propionibacterium acnes
#1773MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS
#1774COMPOSITION FOR INHIBITION OR PREVENTION OF BONE DENSITY REDUCTION
#1775BOTANICAL COMPOSITION FOR ENHANCED SKIN REPAIR AND USES THEREOF
#1776Use of alpha-hydroxy carbonyl compounds as reducing agents
#1777Synergistic anti-inflammatory and antioxidant dietary supplement compositions
#1778USE OF AT LEAST ONE CYTOSOLIC PHOSPHOLIPASE A2 INHIBITOR AS A MEDICINE FOR SYMPTOMATIC TREATMENT OF MUCOVISCIDOSIS
#1779HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS
#1780Compositions and methods of the treatment of obesity and osteoporosis
#1781COMPOUNDS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES
#1782Curcumin derivatives
#1783Methods and Compositions for Treating Viral Hemorrhagic Fever
#1784Solid betalain compositions and methods
#1785Post-translational regulation of catalytic activities of cytochrome P450 46A1 and uses thereof
#1786METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#1787Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#1788COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER
#1789Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same
#1790USE OF CERTAIN CHEMICAL COMPOUNDS FOR THE INHIBITION OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE ACTIVITY OF CYCLOPHILINS
#1791NOVEL USE OF ORGANIC COMPOUNDS
#1792INHIBITORS OF Akt ACTIVITY
#1793Biomimetic Hydroxyapatite Composite Materials and Methods for the Preparation Thereof
#1794IMPROVEMENTS IN RELATION TO CANCER THERAPY
#1795PHARMACEUTICAL COMPOSITION OF ATOVAQUONE
#1796METHODS FOR REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION IN A PATIENT SUFFERING FROM INSOMNIA
#1797DERMATOLOGICAL COMPOSITIONS WITH ANTI-AGING AND SKIN EVEN-TONING PROPERTIES
#1798Integrase Inhibitors 3
#1799Pharmaceutical compositions and methods for peptide treatment
#1800REDUCED-HANGOVER ALCOHOLIC BEVERAGE COMPRISING TURMERIC